Ascentage Pharma
Suzhou · Founded 2009
About Ascentage Pharma
Ascentage Pharma develops novel small-molecule therapies for cancer, hepatitis B, and age-related diseases. They have developed a pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions and are next-generation tyrosine kinase inhibitors.
Company Facts
- Founded: 2009
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $504.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: hkg:6855
- Website: ascentagepharma.com
- Phone: +86 512 855 57777
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ascentage-pharma-38447 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.